15.3 Rational Drug Design and Structure-Activity Relationships

Rational drug design revolutionizes medication development by targeting specific biological structures. This approach cuts costs, boosts success rates, and minimizes side effects. It's all about finding the right molecular fit for maximum effectiveness.

Key techniques like molecular docking and virtual screening help scientists predict and test drug interactions. Success stories include HIV protease inhibitors and targeted cancer therapies, showing how this method can dramatically improve patient outcomes.

Rational Drug Design Fundamentals

Rational drug design process

Top images from around the web for Rational drug design process

• 

  Frontiers | Rational Design of Smart Hydrogels for Biomedical Applications View original

  Is this image relevant?

• 

  Figures and data in NICEdrug.ch, a workflow for rational drug design and systems-level analysis ... View original

  Is this image relevant?

• 

  Frontiers | On the Integration of In Silico Drug Design Methods for Drug Repurposing | Pharmacology View original

  Is this image relevant?

• 

  Frontiers | Rational Design of Smart Hydrogels for Biomedical Applications View original

  Is this image relevant?

• 

  Figures and data in NICEdrug.ch, a workflow for rational drug design and systems-level analysis ... View original

  Is this image relevant?

1 of 3

Top images from around the web for Rational drug design process

• 

  Frontiers | Rational Design of Smart Hydrogels for Biomedical Applications View original

  Is this image relevant?

• 

  Figures and data in NICEdrug.ch, a workflow for rational drug design and systems-level analysis ... View original

  Is this image relevant?

• 

  Frontiers | On the Integration of In Silico Drug Design Methods for Drug Repurposing | Pharmacology View original

  Is this image relevant?

• 

  Frontiers | Rational Design of Smart Hydrogels for Biomedical Applications View original

  Is this image relevant?

• 

  Figures and data in NICEdrug.ch, a workflow for rational drug design and systems-level analysis ... View original

  Is this image relevant?

1 of 3

• Rational drug design systematically develops new medications based on biological target knowledge reduces time and cost of drug development
• Process increases success rate of candidate drugs complements traditional methods (high-throughput screening)
• Key components involve target identification and validation, lead compound discovery, and lead optimization
• Approach proves more efficient than random screening allows for tailored drug design minimizes side effects through targeted approach

Structure-activity relationships in optimization

• Structure-activity relationships (SAR) correlate chemical structure with biological activity serve as fundamental principle in medicinal chemistry
• SAR guides modification of lead compounds helps predict effects of structural changes enables fine-tuning of drug properties
• Analysis identifies key functional groups determines optimal molecular size and shape assesses impact of substituents on activity
• Applications include improving potency and selectivity, enhancing pharmacokinetic properties (bioavailability, half-life), reducing toxicity and side effects

Advanced Techniques and Applications

Techniques for rational drug design

• Molecular docking predicts binding modes of ligands to target proteins uses scoring functions to estimate binding affinity helps in lead optimization and hit identification
• Virtual screening searches large compound libraries in silico employs structure-based and ligand-based approaches filters compounds based on predicted activity
• De novo drug design creates novel molecules from scratch uses fragment-based approaches employs artificial intelligence and machine learning (neural networks, genetic algorithms)
• Quantitative structure-activity relationship (QSAR) modeling correlates molecular properties with biological activity
• Pharmacophore modeling identifies essential features for biological activity guides design of new compounds
• Homology modeling predicts structures of unknown proteins based on similar known structures

Case studies of successful applications

• HIV protease inhibitors:
  1. Structure-based design of saquinavir
  2. Development of multiple protease inhibitors (ritonavir, indinavir)
  3. Revolutionized HIV treatment by targeting viral replication
• Imatinib (Gleevec) targeted therapy for chronic myeloid leukemia designed to inhibit BCR-ABL tyrosine kinase dramatically improved patient outcomes (5-year survival rate from 30% to 90%)
• Neuraminidase inhibitors:
  1. Rational design of zanamivir for influenza treatment
  2. Based on crystal structure of viral neuraminidase
  3. Led to development of oseltamivir (Tamiflu) reduced influenza symptoms and duration
• BRAF inhibitors structure-guided design of vemurafenib targets mutant BRAF in melanoma improved survival rates in metastatic melanoma patients (6-month survival rate from 25% to 84%)